How can I tell if an online compounded semaglutide pharmacy is FDA compliant?

No online compounded semaglutide pharmacy is "FDA-compliant" in the sense of offering an FDA-approved product, because compounded semaglutide itself is not FDA-approved [1][2][4]. However, you can verify if an online pharmacy is legally operating under FDA compounding rules by checking for specific regulatory statuses and accreditation:

1. Verify the Pharmacy Type: 503A vs. 503B

The pharmacy must be either a state-licensed 503A compounding pharmacy or an FDA-registered 503B outsourcing facility:

• 503A: Regulated by state boards; fills prescriptions for individual patients. It cannot compound "essentially copies" of FDA-approved drugs unless the drug is on the shortage list (shortage ended Feb 21, 2025) [2][5].
• 503B (Outsourcing Facility): Federally registered, inspected by the FDA, and follows stricter Current Good Manufacturing Practice (cGMP) regulations [1][2]. This is the most "FDA-aligned" option.

2. Check for Accreditation

Look for accreditation from independent bodies that audit for national compounding standards:

• PCAB (Pharmacy Compounding Accreditation Board): Verify accreditation via the ACHC provider directory [2].
• NABP (National Association of Boards of Pharmacy): Accredited pharmacies demonstrate compliance with USP Chapters 795, 797, and 800 [1][3].
• Use the NABP Safe Site Search Tool to verify the legitimacy of the website [1][3].

3. Confirm Licensing and Ingredients

• Proper Licensing: The pharmacy must hold a valid, active license in good standing (not expired or revoked) with a physical U.S. address and phone number [1].
• FDA-Registered Base: Ensure the pharmacy sources semaglutide base from an FDA-registered facility. Unauthorized sourcing raises quality and safety risks [1].
• Licensed Pharmacist Access: You should be able to speak directly with a licensed pharmacist to answer questions [1].

Important Warning

Since the FDA declared the semaglutide shortage ended in February 2025, routine compounding of "essentially copies" of FDA-approved drugs (like Ozempic or Wegovy) is generally prohibited unless the pharmacy can document a significant medical difference for an individual patient [5][7][10]. If a pharmacy continues to sell standard copies without this documentation, they may be operating unlawfully [3].

Recommendation: The safest route is to obtain FDA-approved Wegovy, Ozempic, or Rybelsus from a local pharmacy. If compromised semaglutide is necessary, prioritize a 503B outsourcing facility or a PCAB/NABP-accredited 503A pharmacy that explicitly states they use FDA-registered base material [1][2].